Submitted by Anonymous (not verified) on 25 August 2023 - 13:42
Opinion/decision on a Paediatric investigation plan (PIP): (1R,2R)-2-[4-(5-methyl-1H-pyrazol-3-yl) benzoyl]-N-(4-oxo-6,7-dihydro-5H-pyrazolo [1,5-a]pyrazin-3-yl)cyclohexanecarboxamide (AZD5718), decision type: , therapeutic area: , PIP number: P/0269/2022
Source: